Overview

Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section

Status:
Completed
Trial end date:
2019-03-07
Target enrollment:
Participant gender:
Summary
This randomized double blind study will be conducted in pregnant woman planned for non elective cesarean section under spinal anesthesia. Ketamine group will receive intravenous 0.25 mg/kg and placebo group will receive same amount of normal saline after spinal anesthesia prior to skin incision. Postoperative outcomes measures are total opioid consumption and pain scores for 24 hrs.
Phase:
Phase 4
Details
Lead Sponsor:
B.P. Koirala Institute of Health Sciences
Treatments:
Analgesics
Ketamine